Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human ALDH1A1 ELISA Kit (AC2618)
Cat.#: ASET-1207
Specifications
Description Human ALDH1A1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human ALDH1A1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.11 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2.5-40 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2075 Human PROKR2 ELISA Kit (AC3486) Quantitative inquiry ASET-1496 Porcine Neuropeptide Y ELISA Kit (AC2907) Quantitative inquiry ASET-1817 Human KCNN4 ELISA Kit (AC3228) Quantitative inquiry ASET-1965 Human 14-3-3 zeta ELISA Kit (AC3376) Quantitative inquiry ASET-1279 Human SLC25A12 ELISA Kit (AC2690) Quantitative inquiry ASET-1458 Human Secretogranin 3 ELISA Kit (AC2869) Quantitative inquiry ASET-1622 Human ASRGL1 ELISA Kit (AC3033) Quantitative inquiry ASET-2173 Human NENF ELISA Kit (AC3584) Quantitative inquiry ASET-1922 Porcine Heme Oxygenase 1 ELISA Kit (AC3333) Quantitative inquiry ASET-2102 Human Ferritin Light Chain ELISA Kit (AC3513) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket